Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma et al. · New England Journal of Medicine · 2003 · 4.2K citations · Full text

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa et al. · New England Journal of Medicine · 2002 · 4K citations · Full text

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Robert J. Fox, David H. Miller, J. Theodore Phillips et al. · New England Journal of Medicine · 2012 · 1.3K citations · Full text

Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy

Hongting Zheng, Samantha A. Whitman, Wei Wu et al. · Diabetes · 2011 · 498 citations · Full text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Ludwig Kappos, Ralf Gold, David H. Miller et al. · The Lancet · 2008 · 477 citations · Full text

Relapsing-remitting Multiple Sclerosis, Medicine, Clinical Neurology +6